E Fund Management Co. Ltd. raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 66.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,652 shares of the company’s stock after acquiring an additional 1,863 shares during the period. E Fund Management Co. Ltd.’s holdings in Henry Schein were worth $322,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the company. Smartleaf Asset Management LLC increased its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the last quarter. CIBC Asset Management Inc increased its position in Henry Schein by 1.0% during the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after acquiring an additional 169 shares during the last quarter. Studio Investment Management LLC increased its position in Henry Schein by 3.8% during the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after acquiring an additional 172 shares during the last quarter. Metis Global Partners LLC increased its position in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after acquiring an additional 187 shares during the last quarter. Finally, Central Pacific Bank Trust Division boosted its stake in shares of Henry Schein by 2.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after purchasing an additional 200 shares during the period. Institutional investors own 96.62% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the stock. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $81.10.
Henry Schein Stock Up 2.2 %
NASDAQ:HSIC opened at $74.59 on Friday. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a 50-day moving average of $74.57 and a 200 day moving average of $72.57. The firm has a market cap of $9.26 billion, a PE ratio of 30.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.
Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.66 earnings per share. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Stories
- Five stocks we like better than Henry Schein
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- How to trade penny stocks: A step-by-step guide
- 3 Stocks to Buy While Others Stay on the Sidelines
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 03/03 – 03/07
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.